Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Trypsin; feces, qualitative

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 84488 refers to a qualitative test for trypsin in feces. This test is designed to measure the levels of fecal trypsin, which is an enzyme produced by the pancreas. Trypsin is initially synthesized as an inactive form known as trypsinogen. This inactive zymogen is secreted into the duodenum through the pancreatic duct, where it is activated by the enzyme enteropeptidase into its active form, trypsin. The primary function of trypsin is to hydrolyze ingested proteins into smaller peptides and amino acids, facilitating their absorption and digestion in the gastrointestinal tract. The measurement of fecal trypsin levels is particularly significant in assessing exocrine pancreatic function. A decrease in trypsin levels in stool samples can indicate insufficient production by the pancreas, which is often associated with conditions such as chronic pancreatitis. In addition to its role in diagnosing pancreatic insufficiency, this test is also utilized as a screening tool for cystic fibrosis in symptomatic newborns and infants. In cystic fibrosis, thick mucus can obstruct the pancreatic ducts, preventing the proper flow of trypsinogen into the small intestine, leading to reduced trypsin levels in feces. It is important to note that for a quantitative assessment of fecal trypsin, CPT® Code 84490 should be used instead.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The qualitative fecal trypsin test (CPT® Code 84488) is indicated for the following conditions:

  • Exocrine Pancreatic Insufficiency This test is performed to evaluate the function of the exocrine pancreas, particularly when there is suspicion of insufficient trypsin production, which may be due to chronic pancreatitis.
  • Cystic Fibrosis Screening The test is also indicated for symptomatic newborns and infants as a screening tool for cystic fibrosis, where the formation of mucous plugs in the pancreatic ducts can obstruct the flow of trypsinogen into the small intestine.

2. Procedure

The procedure for conducting the qualitative fecal trypsin test involves several key steps:

  • Specimen Collection A random stool specimen is collected from the patient. It is essential that the specimen is obtained in a manner that prevents contamination and preserves the integrity of the sample for accurate testing.
  • Testing Method The collected stool sample is then subjected to a semi-quantitative film digestion method. This technique allows for the assessment of trypsin levels in the feces, providing a qualitative result that indicates the presence or absence of trypsin.

3. Post-Procedure

After the fecal trypsin test is completed, the results are analyzed and reported. If decreased levels of trypsin are detected, further evaluation may be warranted to determine the underlying cause, such as chronic pancreatitis or cystic fibrosis. It is important for healthcare providers to interpret the results in conjunction with clinical findings and other diagnostic tests. No specific post-procedure care is required for the patient following the stool collection, but they should be informed about the significance of the test results and any necessary follow-up actions.

Short Descr TEST FECES FOR TRYPSIN
Medium Descr ASSAY OF TRYPSIN FECES QUALITATIVE
Long Descr Trypsin; feces, qualitative
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Changed Medium Descriptor changed.
Pre-1990 Added Code added.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"